Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Discover various ways to maximize your cashback rewards. Enhance your savings strategy and earn more with each purchase!
8,831 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
A veteran Jefferies strategist outlines a split AI spend cycle: upfront hardware capex drives early gains, while long...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
An insider move at a biotech stage company can spark questions. This article breaks down the trade, its timing, and w...
Apple has chosen caution in the AI race, trading near its highs as investors bet on durability and profits over rapid...
SpaceX stock has pulled back after a brisk IPO run, trading in the low to mid 140s as of today. This report breaks do...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
A 67-year-old homeowner with two mortgage-free homes worth millions weighs a HELOC to cover unexpected bills as rates...
Pi Network's Core Team rolled out a major redesign of the mining app and Pioneer profile page, promising clearer navi...
Critics like the billionaire investor jeremy grantham call Bitcoin a mere speculative asset. This article argues why ...
A tempting promise of free phones drew unsuspecting customers into a mailbox scam that police say ended with dozens o...
The Shiba Inu project is under pressure after its official social channel sparked backlash with a controversial poll ...